- Home
- WLKP vs GHRS Comparison
WLKP vs GHRS Comparison
Compare WLKP & GHRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WLKP
- GHRS
- Stock Information
- Founded
- WLKP 2014
- GHRS 2018
- Country
- WLKP United States
- GHRS Ireland
- Employees
- WLKP N/A
- GHRS N/A
- Industry
- WLKP Major Chemicals
- GHRS Biotechnology: Pharmaceutical Preparations
- Sector
- WLKP Industrials
- GHRS Health Care
- Exchange
- WLKP Nasdaq
- GHRS Nasdaq
- Market Cap
- WLKP 817.5M
- GHRS 868.7M
- IPO Year
- WLKP 2014
- GHRS 2021
- Fundamental
- Price
- WLKP $23.14
- GHRS $10.40
- Analyst Decision
- WLKP
- GHRS Strong Buy
- Analyst Count
- WLKP 0
- GHRS 7
- Target Price
- WLKP N/A
- GHRS $30.86
- AVG Volume (30 Days)
- WLKP 22.8K
- GHRS 212.1K
- Earning Date
- WLKP 04-30-2025
- GHRS 05-02-2025
- Dividend Yield
- WLKP 8.10%
- GHRS N/A
- EPS Growth
- WLKP 14.91
- GHRS N/A
- EPS
- WLKP 1.77
- GHRS N/A
- Revenue
- WLKP $1,135,896,000.00
- GHRS N/A
- Revenue This Year
- WLKP $8.90
- GHRS N/A
- Revenue Next Year
- WLKP $6.87
- GHRS N/A
- P/E Ratio
- WLKP $13.12
- GHRS N/A
- Revenue Growth
- WLKP N/A
- GHRS N/A
- 52 Week Low
- WLKP $21.19
- GHRS $6.00
- 52 Week High
- WLKP $25.04
- GHRS $20.50
- Technical
- Relative Strength Index (RSI)
- WLKP 41.11
- GHRS 41.32
- Support Level
- WLKP $23.00
- GHRS $10.20
- Resistance Level
- WLKP $23.45
- GHRS $13.21
- Average True Range (ATR)
- WLKP 0.30
- GHRS 0.85
- MACD
- WLKP -0.01
- GHRS -0.12
- Stochastic Oscillator
- WLKP 21.23
- GHRS 11.37
About WLKP Westlake Chemical Partners LP Common Units representing limited partner interests
Westlake Chemical Partners LP is a part of the chemical industry in the United States. Its operations are conducted through OpCo, it acquires and develops ethylene production facilities, which convert ethane into ethylene. OpCo sells ethylene and its co-products such as propylene, crude butadiene, pyrolysis gasoline, and hydrogen to Westlake and other customers located in the United States. Its assets include three ethylene production facilities in Calvert City, Kentucky, and Lake Charles, Louisiana.
About GHRS GH Research PLC
GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the treatment of psychiatric and neurological disorders. The company is focused on developing novel and proprietary Mebufotenin 5-Methoxy-N, N-Dimethyltryptamine, or 5-MeO-DMT, therapies for the treatment of patients with Treatment-Resistant Depression, or TRD.